Rhumbline Advisers »

Calliditas Therap Adr Rep 2 Ord shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Calliditas Therap Adr Rep 2 Ord (CALT) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Calliditas Therap Adr Rep 2 Ord

Tip: Access up to 7 years of quarterly data

All positions including Calliditas Therap Adr Rep 2 Ord held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calliditas Therap Adr Rep 2 Ord by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.2k 164 25.76
2023-09-30 $2.7k 149 18.26
2023-06-30 $2.2k 139 15.70

More positions owned by Rhumbline Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Tesla Motors (TSLA)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Visa (V)
Exxon Mobil Corporation (XOM)

View all positions for Rhumbline Advisers

Top funds holding Calliditas Therap Adr Rep 2 Ord

BVF
Deutsche Bank Aktiengesellschaft
Ironwood Investment Management
Citadel Advisors
Wells Fargo & Company
Advisor Group Holdings
UBS Group
Planning Capital Management Corp
Simplex Trading
Jpmorgan Chase & Co
Bank of America Corporation
Rhumbline Advisers
Missouri Trust & Investment
Nalls Sherbakoff Group

View all funds holding Calliditas Therap Adr Rep 2 Ord